The U.S. Centers for Disease Control and Prevention (CDC) said in a statement today that five Egyptian rousette fruit bats caught in Sierra Leone tested positive for the Marburg virus, a deadly [Read more]
The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate high payoff potential to Counter-WMD (C-WMD) threats, including chemical, biological, radiological, nuclear [Read more]
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential to cause a public health emergency and the absence of efficacious medical [Read more]
Researchers from the University of Copenhagen and Phillips Universität Marburg have found a new target for inhibiting Ebola virus from copying itself to produce more infection in a host. ‘When the Ebola [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures (MCM) as part of the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE). [Read more]
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, according to [Read more]
A study led by scientists at the University of Texas Medical Branch Galveston National Laboratory and Mapp Biopharmaceutical has found that an experimental treatment cured 100 percent of guinea pigs and rhesus [Read more]
By Rebecca Fish The United States continues to face national security risks from natural, accidental , and intentional health threats. Efforts to improve chemical, biological, radiological and nuclear threats (CBRN) and emerging [Read more]
The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for future use—that occurred from 2003 through 2015 is unknown for several reasons. [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking proposals for advanced development of multivalent vaccines against Ebola virus, Sudan virus, Marburg virus and Lassa fever. The effort also seeks [Read more]
© 2019 STEMAR MEDIA